Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 10
- Registration Number
- NCT04252833
- Locations
- ๐บ๐ธ
Lotus Clinical Resarch,LLC, Pasadena, California, United States
Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT04175743
- Locations
- ๐บ๐ธ
Lotus Clinical Resarch,LLC, Pasadena, California, United States
A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT02199678
- Locations
- ๐บ๐ธ
Prahealthsciences, Salt Lake City, Utah, United States
๐บ๐ธLotus Clinical Research, LLC, Pasadena, California, United States
An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.
- First Posted Date
- 2014-04-02
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 114
- Registration Number
- NCT02101476
- Locations
- ๐บ๐ธ
Lotus Clinical Resarch,LLC, Pasadena, California, United States
Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02096926
- Locations
- ๐บ๐ธ
Lotus Clinical Research, LLC, Pasadena, California, United States
An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT02087748
- Locations
- ๐บ๐ธ
Lotus Clinical Research, LLC, Pasadena, California, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath